OSR Health, Inc. received a Staff Determination Letter from Nasdaq notifying the company of its intent to delist common stock and warrants for non-compliance with the minimum bid price requirement. On August 25, 2026, OSR Health submitted a request for a hearing before a Nasdaq Hearings Panel to appeal this determination. Although the timely hearing request will not stay the scheduled suspension of trading on August 26, 2026, it is expected to prevent the immediate filing of Form 25-NSE pending the panel's decision. The company intends to present a compliance plan at the hearing but provided no assurance that listing would be maintained. OSR Health operates in the healthcare sector, providing medical equipment and services.
